Healthcare -
Biotechnology - NASDAQ - US
$ 2.11
9.33 %
$ 45.7 M
Market Cap
-0.73
P/E
ALRN - STOCK-BASED COMPENSATION
Stock-based Compensation ALRN - Aileron Therapeutics, Inc.
1.19 M
LAST VALUE
-27.44%
2 YEAR CAGR
-18.35%
5 YEAR CAGR
25.27%
10 YEAR CAGR